Hepatitis D: Scenario in the Asia-Pacific region

被引:85
作者
Abbas, Zaigham [1 ]
Jafri, Wasim [2 ]
Raza, Sajjad [3 ]
机构
[1] Sindh Inst Urol & Transplantat, Dept Hepatogastroenterol, Karachi 74200, Sindh, Pakistan
[2] Aga Khan Univ Hosp, Dept Med, Karachi 74800, Pakistan
[3] Dow Med Coll, Karachi 74200, Pakistan
关键词
Hepatitis D; Asia-Pacific region; Prevalence; Epidemiology; D VIRUS-INFECTION; CHRONIC LIVER-DISEASE; B SURFACE-ANTIGEN; HBSAG POSITIVE PATIENTS; DELTA-AGENT INFECTION; HDV INFECTION; SAUDI-ARABIA; DRUG-ABUSERS; CLINICAL IMPACT; SOUTHERN TAIWAN;
D O I
10.3748/wjg.v16.i5.554
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis D virus (HDV) infection is present worldwide and affects all age groups. Around 18 million people are estimated to be infected with HDV. An important trend in HDV infection is global decline. HDV prevalence has decreased significantly in Europe since the 1970s and 1980s when it was first reported. The Asia-Pacific region now seems to be where HDV is a major health concern. There is a lack of available data from most of the countries from this region; hence, the true status of HDV cannot be determined. In South Asia, most of the countries have conditions that are favorable for the spread of hepatitis B and other related infections. Countries like Pakistan and Iran have shown an increase in HDV prevalence over a period of time. Other countries and region like China, Turkey, Australia, Japan, India and Taiwan, some of which had very high HDV prevalence in the past, have shown a decline in the incidence, but high prevalence persists in some. Intravenous drug abusers, homosexual men and women, prostitutes, and people on hemodialysis are the groups with very high HDV prevalence. (C) 2010 Baishideng. All rights reserved.
引用
收藏
页码:554 / 562
页数:9
相关论文
共 103 条
[1]  
AGHANASHINIKAR PN, 1992, TRANSPLANT P, V24, P1913
[2]   Prevalence of hepatitis delta antibody-among HBsAg carriers in Saudi Arabia [J].
Al Traif, I ;
Ali, A ;
Dafalla, M ;
Al Tamimi, W ;
Qassem, L .
ANNALS OF SAUDI MEDICINE, 2004, 24 (05) :343-344
[3]  
Alavian S. M., 2005, GOVARESH, V10, P21
[4]  
Alavian SM, 2008, HEPAT MON, V8, P245
[5]   HEPATITIS-B-VIRUS, DELTA-VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS AMONG OMANI PATIENTS WITH RENAL-DISEASES - A SEROPREVALENCE STUDY [J].
ALDHAHRY, SHS ;
AGHANASHINIKAR, PN ;
ALMARHUBY, HA ;
BUHL, MR ;
DAAR, AS ;
ALHASANI, MK .
ANNALS OF SAUDI MEDICINE, 1994, 14 (04) :312-315
[6]  
Amarapurkar D N, 1992, Indian J Gastroenterol, V11, P11
[7]  
Arakawa Y, 2000, J VIRAL HEPATITIS, V7, P375
[8]  
ARYA SC, 1988, APMIS, V96, P30
[9]  
ASHRAF SJ, 1986, LIVER, V6, P73
[10]   HEPATITIS DELTA VIRUS-INFECTION IN BOMBAY [J].
BANKER, DD ;
DESAI, P ;
BRAWNER, TA ;
DECKER, RH .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1992, 86 (04) :424-425